Cussler K - Search Results

1

[Progress in the replacement of animal experiments in the quality control of clostridial vaccines].

Cussler K, Borrmann E, Werner E. Cussler K, et al. Dtsch Tierarztl Wochenschr. 2002 Apr;109(4):172-7. Dtsch Tierarztl Wochenschr. 2002. PMID: 11998369 Review. German.

2

Development and validation of a serological potency test for the release of Leptospira vaccines--requirements in the European Union.

Balks E, Gyra H, Kobe B, Cussler K, Werner E. Balks E, et al. Among authors: cussler k. Biologicals. 2013 Sep;41(5):325-9. doi: 10.1016/j.biologicals.2013.06.011. Epub 2013 Aug 1. Biologicals. 2013. PMID: 23911253

3

Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.

Ebert E, Oppling V, Werner E, Cussler K. Ebert E, et al. Among authors: cussler k. FEMS Immunol Med Microbiol. 1999 Jul;24(3):299-311. doi: 10.1111/j.1574-695X.1999.tb01298.x. FEMS Immunol Med Microbiol. 1999. PMID: 10397315 Free article.

4

An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.

Ebert E, Kusch M, Öppling V V, Werner E, Cussler K. Ebert E, et al. Among authors: cussler k. ALTEX. 1996;13(2):68-75. ALTEX. 1996. PMID: 11178445 English.

5

Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.

Borrmann E, Schulze F, Cussler K, Hänel I, Diller R. Borrmann E, et al. Among authors: cussler k. Vet Microbiol. 2006 Apr 16;114(1-2):41-50. doi: 10.1016/j.vetmic.2005.10.043. Epub 2005 Dec 19. Vet Microbiol. 2006. PMID: 16361070

6

[100 years of erysipelas prophylaxis: significance and reduction of animal experiments].

Cussler K, Balks E. Cussler K, et al. ALTEX. 2001;18(1):29-33. ALTEX. 2001. PMID: 11248847 German.

7

Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.

Rosskopf-Streicher U, Johannes S, Wilhelm M, Cussler K. Rosskopf-Streicher U, et al. Among authors: cussler k. Vaccine. 2001 Jan 8;19(11-12):1477-83. doi: 10.1016/s0264-410x(00)00346-7. Vaccine. 2001. PMID: 11163671

ALTEX 1994;Suppl. 1:39-45; Rosskopf-Streicher U, Johannes S, Hausleithner D, Gyra H, Cussler K. Suitability of an ELISA for the batch potency test in laboratory mice. Pharmeuropa BIO 1998;1:65-70). ...After a pre-validation study had been performed with success (Ros …

ALTEX 1994;Suppl. 1:39-45; Rosskopf-Streicher U, Johannes S, Hausleithner D, Gyra H, Cussler K. Suitability of an ELISA for th …

8

Humane endpoints in the efficacy testing of swine erysipelas vaccines.

Johannes S, Hartinger J, Hendriksen CF, Morton DB, Cussler K. Johannes S, et al. Among authors: cussler k. ALTEX. 2003;20(1):11-5. ALTEX. 2003. PMID: 12579350 Free article.

9

Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.

Rosskopf-Streicher U, Johannes S, Gyra H, Beckmann R, Cussler K. Rosskopf-Streicher U, et al. Among authors: cussler k. Dev Biol (Basel). 2002;111:153-8. Dev Biol (Basel). 2002. PMID: 12678235

10

[Clinical endpoints during rabies vaccine control tests].

Hartinger J, Folz T, Cussler K. Hartinger J, et al. Among authors: cussler k. ALTEX. 2001;18(1):37-40. ALTEX. 2001. PMID: 11248849 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters